Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Godehard Friedel

Showing results (51-60 of 78) with videos related to

Pageof 8
Sort By:
Anticancer Research|April 9, 2013
Postoperative survival of lung cancer patients: are there predictors beyond TNM?Godehard Friedel, Peter Fritz, Sven Goletz, et al.
Radiology|June 25, 2004
Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging--perfusion differences in malignant and benign lesionsJuergen F Schaefer, Joachim Vollmar, Fritz Schick, et al.
Nuclear Medicine Communications|August 21, 2004
The benefit of functional-anatomical imaging with [18F]fluorodeoxyglucose utilizing a dual-head coincidence gamma camera with an integrated X-ray transmission system in non-small cell lung cancerSusanne M Eschmann, Michael Bitzer, Frank Paulsen, et al.
BMC Cancer|December 17, 2008
Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breastMaike Sonnenberg, Heiko van der Kuip, Silke Haubeis, et al.
Oncotarget|May 15, 2018
A subgroup of pleural mesothelioma expresses ALK protein and may be targetable by combined rapamycin and crizotinib therapyDina Mönch, Sabine Bode-Erdmann, Jörg Kalla, et al.
Journal of Pharmaceutical Sciences|September 23, 2008
Efficient telomerase inhibition in human non-small cell lung cancer cells by liposomal delivery of 2'-O-methyl-RNAJulia Beisner, Meng Dong, Sebastian Taetz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 10, 2006
Low dose non-enhanced CT versus standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning in non-small cell lung cancerAnna C Pfannenberg, Philip Aschoff, Klaus Brechtel, et al.
Pediatric Blood & Cancer|March 4, 2011
Embryonal rhabdomyosarcoma with metastases confined to the lungs: report from the CWS Study GroupTobias M Dantonello, Peter Winkler, Tobias Boelling, et al.
The Journal of Surgical Research|March 20, 2003
Isolated lung perfusion with gemcitabine in a rat: pharmacokinetics and survivalBart P Van Putte, Jeroen M Hendriks, Sander Romijn, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2002
Dose optimization of a doxorubicin prodrug (HMR 1826) in isolated perfused human lungs: low tumor pH promotes prodrug activation by beta-glucuronidaseThomas E Mürdter, Godehard Friedel, Janne T Backman, et al.
Pageof 8

Showing results (51-60 of 78) with videos related to

Sort By:
Pageof 8
Anticancer Research|April 9, 2013
Postoperative survival of lung cancer patients: are there predictors beyond TNM?Godehard Friedel, Peter Fritz, Sven Goletz, et al.
Radiology|June 25, 2004
Solitary pulmonary nodules: dynamic contrast-enhanced MR imaging--perfusion differences in malignant and benign lesionsJuergen F Schaefer, Joachim Vollmar, Fritz Schick, et al.
Nuclear Medicine Communications|August 21, 2004
The benefit of functional-anatomical imaging with [18F]fluorodeoxyglucose utilizing a dual-head coincidence gamma camera with an integrated X-ray transmission system in non-small cell lung cancerSusanne M Eschmann, Michael Bitzer, Frank Paulsen, et al.
BMC Cancer|December 17, 2008
Highly variable response to cytotoxic chemotherapy in carcinoma-associated fibroblasts (CAFs) from lung and breastMaike Sonnenberg, Heiko van der Kuip, Silke Haubeis, et al.
Oncotarget|May 15, 2018
A subgroup of pleural mesothelioma expresses ALK protein and may be targetable by combined rapamycin and crizotinib therapyDina Mönch, Sabine Bode-Erdmann, Jörg Kalla, et al.
Journal of Pharmaceutical Sciences|September 23, 2008
Efficient telomerase inhibition in human non-small cell lung cancer cells by liposomal delivery of 2'-O-methyl-RNAJulia Beisner, Meng Dong, Sebastian Taetz, et al.
European Journal of Nuclear Medicine and Molecular Imaging|August 10, 2006
Low dose non-enhanced CT versus standard dose contrast-enhanced CT in combined PET/CT protocols for staging and therapy planning in non-small cell lung cancerAnna C Pfannenberg, Philip Aschoff, Klaus Brechtel, et al.
Pediatric Blood & Cancer|March 4, 2011
Embryonal rhabdomyosarcoma with metastases confined to the lungs: report from the CWS Study GroupTobias M Dantonello, Peter Winkler, Tobias Boelling, et al.
The Journal of Surgical Research|March 20, 2003
Isolated lung perfusion with gemcitabine in a rat: pharmacokinetics and survivalBart P Van Putte, Jeroen M Hendriks, Sander Romijn, et al.
The Journal of Pharmacology and Experimental Therapeutics|March 22, 2002
Dose optimization of a doxorubicin prodrug (HMR 1826) in isolated perfused human lungs: low tumor pH promotes prodrug activation by beta-glucuronidaseThomas E Mürdter, Godehard Friedel, Janne T Backman, et al.
Pageof 8